๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients

โœ Scribed by S.K Lee; J.H Park; J.W Joh; S.J Kim; I.S Choi; S.H Choi; J.S Heo; W.Y Lee; T.S Sohn; Y.I Kim; S.W Paik; K.C Koh; J.H Lee; S.M Kim; K.R Peck; J.H Song; B.B Lee

Book ID
117229854
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
68 KB
Volume
32
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prophylaxis against hepatitis B recurren
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
โœ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA

Intramuscular hepatitis B immune globuli
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
โœ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro